Device Trial Radar · NCT05189405
3 Year Retrospective Analysis of IVF in Comparison With INVOcell
Last checked: Nov 19, 2026Latest source record: Jan 12, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
450
Planned (sponsor's estimate)
Start
Oct 12, 2021
Primary completion
Feb 28, 2022
Study completion Feb 28, 2022
Sponsor
- Lead sponsor
- INVO Bioscience, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 12, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years, up to 42 years
Summary
As written by the sponsor on the registry.
Retrospective chart review of data on the use of traditional IVF and INVOcell IVC collected from clinics using both technologies. The retrospective data will be utilized for a comparison of the two methods.
Conditions
- Infertility
Interventions
INVOcell IVCDevice
Embryo development in intravaginal incubation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Embryo developmentTime frame: 5 days
- Clinical pregnancy rateTime frame: 5 days
- Live birth rateTime frame: 5 days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Carolina Conceptions
Raleigh, North Carolina
Piedmont Reproductive Endocrinology Group
Greenville, South Carolina
CARE Fertility
Bedford, Texas
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.